scholarly journals Tricuspid Insufficiency Caused by a Ventricular Pacemaker Lead Implanted 23 Years Previously

2021 ◽  
Vol 82 (3) ◽  
pp. 520-524
Author(s):  
Takahisa OKANO ◽  
Katsuji FUJIWARA ◽  
Hitoshi YAKU
Keyword(s):  
Pacemaker Lead ◽  
Tricuspid Insufficiency

Hemodynamic relevant tricuspid insufficiency in the presence of a ventricular pacemaker lead – how to treat?

2009 ◽  
Vol 56 (S 01) ◽  
Author(s):  
B Pfannmüller ◽  
G Hirnle ◽  
J Seeburger ◽  
T Walther ◽  
V Falk ◽  
...  
Keyword(s):  
Pacemaker Lead ◽  
Tricuspid Insufficiency

452 Value of new diagnostic criteria in pacemaker lead endocarditis

1999 ◽  
Vol 1 ◽  
pp. S75-S75
Author(s):  
G HABIB ◽  
P BARNAY ◽  
J AVIERINOS ◽  
G DERUMEAUX ◽  
J LEFEVRE ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Pacemaker Lead ◽  
Lead Endocarditis

scholarly journals Unexpected pacemaker lead in an 84‐year‐old patient

2021 ◽  
Author(s):  
Lauren Sams ◽  
Stefan Brunner ◽  
Michael Näbauer ◽  
Julius Steffen
Keyword(s):  
Pacemaker Lead

scholarly journals Novel extrathoracic puncture techniques for pacemaker lead insertion: Pitfalls of the conventional extrathoracic puncture method

2012 ◽  
Vol 28 (2) ◽  
pp. 111-113 ◽  
Author(s):  
Kohei Sawasaki ◽  
Terumori Sato ◽  
Yohei Takayama ◽  
Shigeki Yokota ◽  
Yasuhiro Morita ◽  
...  
Keyword(s):  
Pacemaker Lead

scholarly journals Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation

2021 ◽  
Author(s):  
Martin Riesenhuber ◽  
Andreas Spannbauer ◽  
Marianne Gwechenberger ◽  
Thomas Pezawas ◽  
Christoph Schukro ◽  
...  
Keyword(s):  
Mitral Regurgitation ◽  
Right Ventricular ◽  
Tricuspid Regurgitation ◽  
Pacemaker Implantation ◽  
Ventricular Dilatation ◽  
Pacemaker Lead ◽  
Survival Analyses ◽  
Before And After ◽  
Right Ventricular Dilatation ◽  
Survival Predictors

Abstract Background Transcatheter tricuspid valve intervention became an option for pacemaker lead-associated tricuspid regurgitation. This study investigated the progression of tricuspid regurgitation (TR) in patients with or without pre-existing right ventricular dilatation (RVD) undergoing pacemaker implantation. Methods Patients were included if they had implantation of transtricuspid pacemaker lead and completed echocardiography before and after implantation. The cohort was divided in patients with and without RVD (cut-off basal RV diameter ≥ 42 mm). TR was graded in none/mild, moderate, and severe. Worsening of one grade was defined as progression. Survival analyses were plotted for 10 years. Results In total, 990 patients were analyzed (24.5% with RVD). Progression of TR occurred in 46.1% of patients with RVD and in 25.6% of patients without RVD (P < 0.001). Predictors for TR progression were RV dilatation (OR 2.04; 95% CI 1.27–3.29; P = 0.003), pre-existing TR (OR 4.30; 95% CI 2.51–7.38; P < 0.001), female sex (OR 1.68; 95% CI 1.16–2.43; P = 0.006), single RV lead (OR 1.67; 95% CI 1.09–2.56; P = 0.018), mitral regurgitation (OR 2.08; 95% CI 1.42–3.05; P < 0.001), and enlarged left atrium (OR 1.98; 95% CI 1.07–3.67; P = 0.03). Survival-predictors were pacemaker lead-associated TR (HR 1.38; 95% CI 1.04–1.84; P = 0.028), mitral regurgitation (HR 1.34; 95% CI 1.02–1.77; P = 0.034), heart failure (HR 1.75; 95% CI 1.31–2.33; P < 0.001), kidney disease (HR 1.62; 95% CI 1.25–2.11; P < 0.001), and age ≥ 80 years (HR 2.84; 95% CI 2.17–3.71; P < 0.001). Conclusions Patients with RVD receiving pacemaker suffered from increased TR progression, leading to decreased survival. Graphic abstract

Sign in / Sign up

Export Citation Format

Share Document